APA
Mackey J. R., Martin M., Pienkowski T., Rolski J., Guastalla J., Sami A., Glaspy J., Juhos E., Wardley A., Fornander T., Hainsworth J., Coleman R., Modiano M. R., Vinholes J., Pinter T., Rodríguez-Lescure A., Colwell B., Whitlock P., Provencher L., Laing K., Walde D., Price C., Hugh J. C., Childs B. H., Bassi K., Lindsay M., Wilson V., Rupin M., Houé V. & Vogel C. (20130403). Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. : The Lancet. Oncology.
Chicago
Mackey John R, Martin Miguel, Pienkowski Tadeusz, Rolski Janusz, Guastalla Jean-Paul, Sami Amer, Glaspy John, Juhos Eva, Wardley Andrew, Fornander Tommy, Hainsworth John, Coleman Robert, Modiano Manuel R, Vinholes Jeferson, Pinter Tamas, Rodríguez-Lescure Alvaro, Colwell Bruce, Whitlock Pierre, Provencher Louise, Laing Kara, Walde David, Price Chris, Hugh Judith C, Childs Barrett H, Bassi Kimberly, Lindsay Mary-Ann, Wilson Véronique, Rupin Matthieu, Houé Vincent and Vogel Charles. 20130403. Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. : The Lancet. Oncology.
Harvard
Mackey J. R., Martin M., Pienkowski T., Rolski J., Guastalla J., Sami A., Glaspy J., Juhos E., Wardley A., Fornander T., Hainsworth J., Coleman R., Modiano M. R., Vinholes J., Pinter T., Rodríguez-Lescure A., Colwell B., Whitlock P., Provencher L., Laing K., Walde D., Price C., Hugh J. C., Childs B. H., Bassi K., Lindsay M., Wilson V., Rupin M., Houé V. and Vogel C. (20130403). Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. : The Lancet. Oncology.
MLA
Mackey John R, Martin Miguel, Pienkowski Tadeusz, Rolski Janusz, Guastalla Jean-Paul, Sami Amer, Glaspy John, Juhos Eva, Wardley Andrew, Fornander Tommy, Hainsworth John, Coleman Robert, Modiano Manuel R, Vinholes Jeferson, Pinter Tamas, Rodríguez-Lescure Alvaro, Colwell Bruce, Whitlock Pierre, Provencher Louise, Laing Kara, Walde David, Price Chris, Hugh Judith C, Childs Barrett H, Bassi Kimberly, Lindsay Mary-Ann, Wilson Véronique, Rupin Matthieu, Houé Vincent and Vogel Charles. Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. : The Lancet. Oncology. 20130403.